IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 63 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $10,509,000 | -19.4% | 7,961,747 | +12.3% | 0.00% | -100.0% |
| Q1 2018 | $13,040,000 | -6.5% | 7,087,133 | +7.2% | 0.00% | 0.0% |
| Q4 2017 | $13,945,000 | +15.1% | 6,609,239 | +21.6% | 0.00% | 0.0% |
| Q3 2017 | $12,120,000 | +36.0% | 5,435,147 | +4.9% | 0.00% | – |
| Q2 2017 | $8,911,000 | -28.0% | 5,181,108 | +3.5% | 0.00% | -100.0% |
| Q1 2017 | $12,368,000 | +70.1% | 5,007,333 | +3.3% | 0.00% | – |
| Q4 2016 | $7,271,000 | -26.1% | 4,847,505 | +26.2% | 0.00% | -100.0% |
| Q3 2016 | $9,834,000 | +79.6% | 3,841,194 | +7.3% | 0.00% | – |
| Q2 2016 | $5,475,000 | -24.6% | 3,578,331 | -2.4% | 0.00% | – |
| Q1 2016 | $7,259,000 | -32.8% | 3,666,124 | +4.9% | 0.00% | -100.0% |
| Q4 2015 | $10,798,000 | -92.9% | 3,494,198 | -68.7% | 0.00% | -83.3% |
| Q3 2015 | $152,665,000 | +1181.6% | 11,171,454 | +247.9% | 0.01% | +500.0% |
| Q2 2015 | $11,912,000 | +5.8% | 3,210,859 | +5.8% | 0.00% | 0.0% |
| Q1 2015 | $11,261,000 | +9.3% | 3,035,280 | +30.0% | 0.00% | 0.0% |
| Q4 2014 | $10,299,000 | +93.9% | 2,335,456 | +0.7% | 0.00% | – |
| Q3 2014 | $5,311,000 | -13.3% | 2,319,072 | +9.8% | 0.00% | – |
| Q2 2014 | $6,128,000 | -16.8% | 2,113,028 | +17.0% | 0.00% | -100.0% |
| Q1 2014 | $7,367,000 | +46.1% | 1,805,620 | +65.8% | 0.00% | – |
| Q4 2013 | $5,043,000 | +16167.7% | 1,089,176 | +5892.1% | 0.00% | – |
| Q3 2013 | $31,000 | +181.8% | 18,177 | -0.0% | 0.00% | – |
| Q2 2013 | $11,000 | – | 18,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|